Cargando…
EGFR基因20外显子插入突变在非小细胞肺癌的研究及其进展
Lung cancer has the highest morbidity and mortality among malignant tumors worldwidely. Targeted therapy related to non-small cell lung cancer (NSCLC) is the research hotspot in recent year. The emergence of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has brought a huge c...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049789/ https://www.ncbi.nlm.nih.gov/pubmed/32093456 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.07 |